KKKiwamu Kudo

Kiwamu Kudo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kiwamu Kudo has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Distinct manifestations of excitatory-inhibitory imbalance associated with amyloid-β and tau in patients with Alzheimer’s disease

    by Kamalini G. Ranasinghe, Kiwamu Kudo, Faatimah Syed, Claire Yballa, Joel H. Kramer, Bruce L. Miller, Katherine P. Rankin, Paul A. Garcia, Heidi E. Kirsch, Keith Vossel, et al.

    A growing body of evidence shows that epileptic activity is frequently observed in patients with Alzheimer’s disease (AD), implicating underlying excitatory-inhibitory imbalance. The distinction of whether the AD-epileptic phenotype represents a subset of patients or an underdiagnosed manifestation holds major therapeutic implications. Here, we quantified the excitatory-inhibitory imbalance in AD patients using magnetoencephalography and examined the relationships to AD pathophysiology—amyloid-beta and tau, and to epileptic activity. We used two metrics to quantify regional excitatory-inhibitory imbalance distinguishing between local hyperexcitability (Neural excitability, quantified by regional aperiodic spectral slope) and aberrant long-range synaptic input integration (Neural fragility, quantified by regional linear dynamic instability). We found that amyloid-beta correlated with higher neural fragility and higher neural excitability, while tau and hypometabolism uniquely correlated with higher neural excitability. Importantly, the AD-epileptic phenotype showed a distinctive increase in neural fragility. Our findings demonstrate that AD pathophysiology is associated with diverse mechanisms of excitatory-inhibitory imbalance and that AD-epileptic phenotype represents a distinct group of patients with greater impairments in long-range synaptic input integration.


  • Open Access

    Neurophysiological trajectories in Alzheimer’s disease progression

    by Kiwamu Kudo, Kamalini G Ranasinghe, Hirofumi Morise, Faatimah Syed, Kensuke Sekihara, Katherine P Rankin, Bruce L Miller, Joel H Kramer, Gil D Rabinovici, Keith Vossel, et al.

    Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β and misfolded tau proteins causing synaptic dysfunction, and progressive neurodegeneration and cognitive decline. Altered neural oscillations have been consistently demonstrated in AD. However, the trajectories of abnormal neural oscillations in AD progression and their relationship to neurodegeneration and cognitive decline are unknown. Here, we deployed robust event-based sequencing models (EBMs) to investigate the trajectories of long-range and local neural synchrony across AD stages, estimated from resting-state magnetoencephalography. The increases in neural synchrony in the delta-theta band and the decreases in the alpha and beta bands showed progressive changes throughout the stages of the EBM. Decreases in alpha and beta band synchrony preceded both neurodegeneration and cognitive decline, indicating that frequency-specific neuronal synchrony abnormalities are early manifestations of AD pathophysiology. The long-range synchrony effects were greater than the local synchrony, indicating a greater sensitivity of connectivity metrics involving multiple regions of the brain. These results demonstrate the evolution of functional neuronal deficits along the sequence of AD progression.


  • Open Access

    Abnormal gamma phase-amplitude coupling in the parahippocampal cortex is associated with network hyperexcitability in Alzheimer’s disease

    by Pooja Prabhu, Hirofumi Morise, Kiwamu Kudo, Alexander Beagle, Danielle Mizuiri, Faatimah Syed, Karunakar A Kotegar, Anne Findlay, Bruce L Miller, Joel H Kramer, et al.

    While animal models of Alzheimer’s disease (AD) have shown altered gamma oscillations (∼40 Hz) in local neural circuits, the low signal-to-noise ratio of gamma in the resting human brain precludes its quantification via conventional spectral estimates. Phase-amplitude coupling (PAC) indicating the dynamic integration between the gamma amplitude and the phase of low-frequency (4–12 Hz) oscillations is a useful alternative to capture local gamma activity. In addition, PAC is also an index of neuronal excitability as the phase of low-frequency oscillations that modulate gamma amplitude, effectively regulates the excitability of local neuronal firing. In this study, we sought to examine the local neuronal activity and excitability using gamma PAC, within brain regions vulnerable to early AD pathophysiology—entorhinal cortex and parahippocampus, in a clinical population of patients with AD and age-matched controls. Our clinical cohorts consisted of a well-characterized cohort of AD patients (n = 50; age, 60 ± 8 years) with positive AD biomarkers, and age-matched, cognitively unimpaired controls (n = 35; age, 63 ± 5.8 years). We identified the presence or the absence of epileptiform activity in AD patients (AD patients with epileptiform activity, AD-EPI+, n = 20; AD patients without epileptiform activity, AD-EPI−, n = 30) using long-term electroencephalography (LTM-EEG) and 1-hour long magnetoencephalography (MEG) with simultaneous EEG. Using the source reconstructed MEG data, we computed gamma PAC as the coupling between amplitude of the gamma frequency (30–40 Hz) with phase of the theta (4–8 Hz) and alpha (8–12 Hz) frequency oscillations, within entorhinal and parahippocampal cortices. We found that patients with AD have reduced gamma PAC in the left parahippocampal cortex, compared to age-matched controls. Furthermore, AD-EPI+ patients showed greater reductions in gamma PAC than AD-EPI− in bilateral parahippocampal cortices. In contrast, entorhinal cortices did not show gamma PAC abnormalities in patients with AD. Our findings demonstrate the spatial patterns of altered gamma oscillations indicating possible region-specific manifestations of network hyperexcitability within medial temporal lobe regions vulnerable to AD pathophysiology. Greater deficits in AD-EPI+ suggests that reduced gamma PAC is a sensitive index of network hyperexcitability in AD patients. Collectively, the current results emphasize the importance of investigating the role of neural circuit hyperexcitability in early AD pathophysiology and explore its potential as a modifiable contributor to AD pathobiology.


  • Open Access

    Neurophysiological trajectories in Alzheimer’s disease progression

    by Kiwamu Kudo, Kamalini G. Ranasinghe, Hirofumi Morise, Faatimah Syed, Kensuke Sekihara, Katherine P. Rankin, Bruce L. Miller, Joel H. Kramer, Gil D. Rabinovici, Keith Vossel, et al.

    Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β and misfolded tau proteins causing synaptic dysfunction and progressive neurodegeneration and cognitive decline. Altered neural oscillations have been consistently demonstrated in AD. However, the trajectories of abnormal neural oscillations in AD progression and their relationship to neurodegeneration and cognitive decline are unknown. Here, we deployed robust event-based sequencing models (EBMs) to investigate the trajectories of long-range and local neural synchrony across AD stages, estimated from resting-state magnetoencephalography. Increases in neural synchrony in the delta-theta band and decreases in the alpha and beta bands showed progressive changes along the EBM stages. Decreases in alpha and beta-band synchrony preceded both neurodegeneration and cognitive decline, indicating that frequency-specific neuronal synchrony abnormalities are early manifestations of AD pathophysiology. The long-range synchrony effects were greater than the local synchrony, indicating a greater sensitivity of connectivity metrics involving multiple regions of the brain. These results demonstrate the evolution of functional neuronal deficits along the sequence of AD progression.


  • Open Access

    Neurophysiological changes associated with plasma p‐tau represent functional effects of amyloid accumulation and are modulated by APOE.

    by Kamalini G Ranasinghe, Julio C. Rojas, Kaitlin B. Casaletto, Kiwamu Kudo, Faatimah Syed, Renaud La Joie, Brandon Chan, Argentina Lario Lago, Bruce L Miller, Keith Vossel, et al.

    Background: Alzheimer disease (AD) is defined by the presence of cerebral amyloid‐β plaques and tau neurofibrillary tangles (NFT). Neurophysiological manifestations which depict the functional changes of neurons and circuits, demonstrate that amyloid‐β and tau have distinct effects—high cerebral amyloid‐β burden is associated with increased neural oscillatory activity while high tau burden with decreased activity. With the recent proliferation of fluid biomarkers, plasma p‐tau181 is known to reflect accumulation of amyloid‐β as well as tau, detected from molecular imaging and neuropathological analyses. It remains unknown whether the neurophysiological consequences of soluble p‐tau reflects the effects of amyloid‐β or those of NFT.Method: We used multimodal imaging combining magnetoencephalography (MEG) to cross‐sectionally study the spectral signatures and positron emission tomography with Aβ binding tracers to define the global amyloid burden in early‐stage neuropathological spectrum including Aβ+ cognitively‐unimpaired (CU, n = 9), Aβ+ mild‐cognitive‐impairment (MCI, n = 20), and Aβ‐negative CU controls (n = 45). Plasma p‐tau181 and neurofilament light (NFL) were measured with Simoa. Using statistical mixed models we examined the associations of neural oscillatory signatures with plasma p‐tau181 and NFL.Result: The characteristic oscillatory signature of increased delta‐theta and reduced alpha spectrum were detectable even in the earliest stages of global amyloid accumulation (Aβ+CU vs. Aβ‐CU; Fig.1). Increased p‐tau181 was associated with increased spectral signatures across the frequency spectrum in Aβ+ individuals (Fig.2). These positive correlations were more robust within delta‐theta (2‐7Hz) than alpha (8‐12 Hz) spectrum. Plasma NFL in Aβ+ individuals, in contrast, was associated with reduced spectral signatures. We also found APOE‐ɛ4 carriers have greater degree of neurodegeneration which modulated the associations between p‐tau181 and neural oscillations (Fig.3).Conclusion: Previous neurophysiological studies have demonstrated that Aβ accumulation is associated with increased oscillatory activity while tau accumulation is associated with reduced oscillatory activity. Positive correlations of p‐tau181 across the spectrum is therefore consistent with the effects of Aβ accumulation and not with tau accumulation. Plasm NFL may represent early effects of neurodegeneration. Collectively our findings indicate that p‐tau181 reflects earliest functional effects of Aβ rather than tau and have implications for the interpretation of plasma p‐tau along the AT(N) stages.

  • Open Access

    Cortical Synchrony and Information Flow during Transition from Wakefulness to Light Non-Rapid Eye Movement Sleep

    by Joline M. Fan, Kiwamu Kudo, Parul Verma, Kamalini G. Ranasinghe, Hirofumi Morise, Anne M. Findlay, Keith Vossel, Heidi E. Kirsch, Ashish Raj, Andrew D. Krystal, et al.

    Sleep is a highly stereotyped phenomenon, requiring robust spatiotemporal coordination of neural activity. Understanding how the brain coordinates neural activity with sleep onset can provide insights into the physiological functions subserved by sleep and the pathologic phenomena associated with sleep onset. We quantified whole-brain network changes in synchrony and information flow during the transition from wakefulness to light non-rapid eye movement (NREM) sleep, using MEG imaging in a convenient sample of 14 healthy human participants (11 female; mean 63.4 years [SD 11.8 years]). We furthermore performed computational modeling to infer excitatory and inhibitory properties of local neural activity. The transition from wakefulness to light NREM was identified to be encoded in spatially and temporally specific patterns of long-range synchrony. Within the delta band, there was a global increase in connectivity from wakefulness to light NREM, which was highest in frontoparietal regions. Within the theta band, there was an increase in connectivity in fronto-parieto-occipital regions and a decrease in temporal regions from wakefulness to Stage 1 sleep. Patterns of information flow revealed that mesial frontal regions receive hierarchically organized inputs from broad cortical regions upon sleep onset, including direct inflow from occipital regions and indirect inflow via parieto-temporal regions within the delta frequency band. Finally, biophysical neural mass modeling demonstrated changes in the anterior-to-posterior distribution of cortical excitation-to-inhibition with increased excitation-to-inhibition model parameters in anterior regions in light NREM compared with wakefulness. Together, these findings uncover whole-brain corticocortical structure and the orchestration of local and long-range, frequency-specific cortical interactions in the sleep-wake transition. SIGNIFICANCE STATEMENT Our work uncovers spatiotemporal cortical structure of neural synchrony and information flow upon the transition from wakefulness to light non-rapid eye movement sleep. Mesial frontal regions were identified to receive hierarchically organized inputs from broad cortical regions, including both direct inputs from occipital regions and indirect inputs via the parieto-temporal regions within the delta frequency range. Biophysical neural mass modeling revealed a spatially heterogeneous, anterior-posterior distribution of cortical excitation-to-inhibition. Our findings shed light on the orchestration of local and long-range cortical neural structure that is fundamental to sleep onset, and support an emerging view of cortically driven regulation of sleep homeostasis.


  • Open Access

    Dynamic functional connectivity MEG features of Alzheimer’s disease

    by Huaqing Jin, Kamalini G. Ranasinghe, Pooja Prabhu, Corby Dale, Yijing Gao, Kiwamu Kudo, Keith Vossel, Ashish Raj, Srikantan S. Nagarajan, Fei Jiang


  • Open Access

    Abnormal gamma frequency phase‐amplitude coupling associated with network hyperexcitability in Alzheimer’s Disease

    by Pooja Prabhu, Kamalini G Ranasinghe, Hirofumi Morise, Kiwamu Kudo, Leighton B Hinkley, Hannah M Lerner, Danielle Mizuiri, Abigail Licata, Karunakar A Kotegar, Anne Findlay, et al.

    Background: Alzheimer’s disease (AD) carries an increased risk of seizures and subclinical epileptiform activity (Vossel et al. 2016). Network hyperexcitability which is the underlying phenomenon of epileptic manifestations is thought to contribute to AD pathophysiological processes. Recently we demonstrated that greater degree of neural synchronization deficits within 2‐8Hz range of frequency oscillations are sensitive indicators of network hyperexcitability (Ranasinghe et al. 2021). Here, we sought to examine the high frequency gamma band deficits associated with network hyperexcitability in AD patients.Methods: Specifically, we quantified Phase Amplitude Coupling (PAC) between the amplitude of gamma oscillations (30‐40Hz); with the phase of 2‐8Hz oscillations) (Figure 1). We used 60s resting‐state magnetoencephalography (MEG) recordings from 48 AD patients (n = 22, with subclinical epileptiform activity, AD‐EPI+; n = 28 without subclinical epileptiform activity, AD‐EPI‐), and 35 age‐matched controls. We computed PAC for each of 68 cortical regions (Desikan et al. 2006) on source‐space reconstructed MEG signal using the mean vector length (Canolty et al. 2006).Results: Permutation cluster test was performed for statistical comparisons between AD patients vs. age matched controls, and AD‐EPI+ vs. AD‐EPI‐. Patients with AD showed significantly higher theta (4‐8 Hz)‐gamma coupling in the left parahippocampal and right caudal‐middle frontal regions. Importantly, this increased left parahippocampal theta‐gamma coupling was significantly higher in AD‐EPI+ patients than in AD‐EPI‐. AD‐EPI+ also showed higher alpha (8‐12Hz)‐gamma coupling in the right parahippocampal region compared to AD‐EPI‐ (Figure 2).Conclusion: These results not only identify gamma band coupling deficits specifically localized to medial temporal regions which are the earliest affected regions in AD pathophysiology but also delineate the associated vulnerabilities of network hyperexcitability in AD.

  • Open Access

    Neurophysiological trajectories in Alzheimer's disease progression

    by Kiwamu Kudo, Kamalini G. Ranasinghe, Hirofumi Morise, Faatimah Syed, Kensuke Sekihara, Katherine P. Rankin, Bruce L. Miller, Joel H. Kramer, Gil D. Rabinovici, Keith Vossel, et al.

    Alzheimer’s disease (AD) is characterized by accumulation of amyloid-β and misfolded tau proteins causing synaptic dysfunction and progressive neurodegeneration and cognitive decline. Altered neural oscillations have been consistently demonstrated in AD. However, the trajectories of abnormal neural oscillations in AD progression and their relation to neurodegeneration and cognitive decline are unknown. We deployed robust event-based sequencing models (EBM) to investigate trajectories of long-range and local neural synchrony across AD stages, estimated from resting-state magnetoencephalography. Synchrony increases in delta-theta and decreases in alpha and beta bands showed progressive changes along the EBM stages of AD. Decreases in alpha and beta synchrony preceded both neurodegeneration and cognitive decline, indicating that frequency-specific neuronal synchrony abnormalities are early manifestations of AD pathophysiology. Long-range synchrony effects were larger than local synchrony, indicating greater sensitivity of connectivity metrics involving multiple brain regions. These results demonstrate the evolution of functional neuronal deficits along the sequence of AD progression.


  • Open Access

    Altered excitatory and inhibitory neuronal subpopulation parameters are distinctly associated with tau and amyloid in Alzheimer’s disease

    by Kamalini G Ranasinghe, Parul Verma, Chang Cai, Xihe Xie, Kiwamu Kudo, Xiao Gao, Hannah Lerner, Danielle Mizuiri, Amelia Strom, Leonardo Iaccarino, et al.

    Background: Neuronal- and circuit-level abnormalities of excitation and inhibition are shown to be associated with tau and amyloid-beta (Aβ) in preclinical models of Alzheimer’s disease (AD). These relationships remain poorly understood in patients with AD.Methods: Using empirical spectra from magnetoencephalography and computational modeling (neural mass model), we examined excitatory and inhibitory parameters of neuronal subpopulations and investigated their specific associations to regional tau and Aβ, measured by positron emission tomography, in patients with AD.Results: Patients with AD showed abnormal excitatory and inhibitory time-constants and neural gains compared to age-matched controls. Increased excitatory time-constants distinctly correlated with higher tau depositions while increased inhibitory time-constants distinctly correlated with higher Aβ depositions.Conclusions: Our results provide critical insights about potential mechanistic links between abnormal neural oscillations and cellular correlates of impaired excitatory and inhibitory synaptic functions associated with tau and Aβ in patients with AD.Funding: This study was supported by the National Institutes of Health grants: K08AG058749 (KGR), F32AG050434-01A1 (KGR), K23 AG038357 (KAV), P50 AG023501, P01 AG19724 (BLM), P50-AG023501 (BLM and GDR), R01 AG045611 (GDR); AG034570, AG062542 (WJ); NS100440 (SSN), DC176960 (SSN), DC017091 (SSN), AG062196 (SSN); a grant from John Douglas French Alzheimer’s Foundation (KAV); grants from Larry L. Hillblom Foundation: 2015-A-034-FEL (KGR), 2019-A-013-SUP (KGR); grants from the Alzheimer’s Association: AARG-21-849773 (KGR); PCTRB-13-288476 (KAV), and made possible by Part the CloudTM (ETAC-09-133596); a grant from Tau Consortium (GDR and WJJ), and a gift from the S. D. Bechtel Jr. Foundation.